Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


GUIDELINE TITLE

VA/DoD clinical practice guideline for the management of diabetes mellitus.

BIBLIOGRAPHIC SOURCE(S)

  • Veterans Health Administration, Department of Defense. VA/DoD clinical practice guideline for the management of diabetes mellitus. Washington (DC): Veterans Health Administration, Department of Defense; 2003 Sep. Various p.

REFERENCES SUPPORTING THE RECOMMENDATIONS

  • A PBM-map guideline for the pharmacological management of hyperlipidemia.Veterans Health Administration, Diabetes Mellitus Working Group; 1997 


  • Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med 1997 Jan 27;157(2):181-8. PubMed


  • Agardh E, Agardh CD, Koul S, Torffvit O. A four-year follow-up study on the incidence of diabetic retinopathy in older onset diabetes mellitus. Diabet Med 1994 Apr;11(3):273-8. PubMed


  • Ahroni JH. Teaching foot care creatively and successfully. Diabetes Educ 1993 Jul-Aug;19(4):320-1, 323-4. PubMed


  • American Diabetes Association (ADA). Standards of medical care for patients with diabetes mellitus. American Diabetes Association. Diabetes Care 1995 Jan;18(Suppl 1):8-15.


  • American Diabetes Association. Position statement: diabetic nephropathy. Diabetes Care 1997;20(Suppl 1):S24-S27.


  • American Diabetes Association: clinical practice recommendations 2002. Diabetes Care 2002 Jan;25 Suppl 1:S1-147. PubMed


  • Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int 2000 Feb;57(2):601-6. PubMed


  • Anderson RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC. Patient empowerment. Results of a randomized controlled trial. Diabetes Care 1995 Jul;18(7):943-9. PubMed


  • Arseneau DL, Mason AC, Wood OB, Schwab E, Green D. A comparison of learning activity packages and classroom instruction for diet management of patients with non-insulin-dependent diabetes mellitus. Diabetes Educ 1994 Nov-Dec;20(6):509-14. PubMed


  • Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators. JAMA 1992 Sep 9;268(10):1292-300. PubMed


  • Aubert RE, Herman WH, Waters J, Moore W, Sutton D, Peterson BL, Bailey CM, Koplan JP. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Intern Med 1998 Oct 15;129(8):605-12. PubMed


  • Bailey TS, Yu HM, Rayfield EJ. Patterns of foot examination in a diabetes clinic. Am J Med 1985 Mar;78(3):371-4. PubMed


  • Bakris GL, Weir MR, DeQuattro V, McMahon FG. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney Int 1998 Oct;54(4):1283-9. PubMed


  • Barth R, Campbell LV, Allen S, Jupp JJ, Chisholm DJ. Intensive education improves knowledge, compliance, and foot problems in type 2 diabetes. Diabet Med 1991 Feb-Mar;8(2):111-7. PubMed


  • Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving HH, Steffes MW, Striker GE. Sc. Am J Kidney Dis 1995 Jan;25(1):107-12. PubMed


  • Birke JA, Sims DS. The insensitive foot. In: Hunt GC, editor(s). Physical therapy of the foot and ankle. New York (NY): Churchill Livingstone; 1988. p. 133-68.


  • Bloomgarden ZT. American Diabetes Association 60th Scientific Sessions, 2000: the diabetic foot. Diabetes Care 2001 May;24(5):946-51. PubMed


  • Bode BW, Strange P. Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes. Diabetes Care 2001 Jan;24(1):69-72. PubMed


  • Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med 1996 Nov;13(11):967-72. PubMed


  • Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001 Sep 20;345(12):861-9. PubMed


  • Brodsky JW, Schneidler C. Diabetic foot infections. Orthop Clin North Am 1991 Jul;22(3):473-89. [29 references] PubMed


  • Campeau L, Knatterud L, Damanski M, Hunninghake DB, White CW, Geller NL, Rosenberg Y. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. The Post Coronary Artery Bypass Graft Trial Investigators. N Engl J Med 1997 Jan 16;336(3):153-62. PubMed


  • Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ, Friedewald W. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986 Dec;8(6):1245-55. PubMed


  • Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994 Sep 29;331(13):854-60. PubMed


  • Carrington AL, Abbott CA, Griffiths J, Jackson N, Johnson SR, Kulkarni J, Van Ross ER, Boulton AJ. Peripheral vascular and nerve function associated with lower limb amputation in people with and without diabetes. Clin Sci (Lond) 2001 Sep;101(3):261-6. PubMed


  • Chen MS, Kao CS, Fu CC, Chen CJ, Tai TY. Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up. Int J Epidemiol 1995 Aug;24(4):787-95. PubMed


  • Chilcott J, Tappenden P, Jones ML, Wight JP. A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus. Clin Ther 2001 Nov;23(11):1792-823; discussion 1791. [34 references] PubMed


  • Ciavarella A, Di Mizio G, Stefoni S, Borgnino LC, Vannini P. Reduced albuminuria after dietary protein restriction in insulin-dependent diabetic patients with clinical nephropathy. Diabetes Care 1987 Jul-Aug;10(4):407-13. PubMed


  • Collins R, Baigent C, Sandercock P, Peto R. Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration. BMJ 1994 Nov 5;309(6963):1215-7. [24 references] PubMed


  • Conget I, Jansa M, Vidal M, Vidal J, Manzanares JM, Gomis R. Effects of an individual intensive educational control program for insulin-dependent diabetic subjects with poor metabolic control. Diabetes Res Clin Pract 1995 Mar;27(3):189-92. PubMed


  • Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. American Diabetes Association and the National Kidney Foundation. Diabetes Care 1994 Nov;17(11):1357-61. [5 references] PubMed


  • Conte MS, Belkin M, Donaldson MC, Baum P, Mannick JA, Whittemore AD. Femorotibial bypass for claudication: do results justify an aggressive approach. J Vasc Surg 1995 Jun;21(6):873-80; discussion 880-1. PubMed


  • Coranian P, Harstall C. Patient diabetes education in the management of adult type 2 diabetes. Alberta (ON): Alberta Heritage Foundation for Medical Research; 2001.  (Series A, Health technology assessment; no. HTA 23).


  • Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R. Self-monitoring in Type 2 diabetes mellitus: a meta-analysis. Diabet Med 2000 Nov;17(11):755-61. PubMed


  • Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996 Dec 18;276(23):1886-92. PubMed


  • Currie IC, Wilson YG, Baird RN, Lamont PM. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg 1995 Oct;10(3):356-61. PubMed


  • Dasbach EJ, Fryback DG, Newcomb PA, Klein R, Klein BE. Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care 1991 Jan;29(1):20-39. PubMed


  • Davidson JK, Delcher HK, Englund A. Spin-off cost/benefits of expanded nutritional care. J Am Diet Assoc 1979 Sep;75(3):250-7.


  • de Gaetano G. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001 Jan 13;357(9250):89-95. PubMed


  • Delahanty L, Simkins SW, Camelon K. Expanded role of the dietitian in the Diabetes Control and Complications Trial: implications for clinical practice. The DCCT Research Group. J Am Diet Assoc 1993 Jul;93(7):758-64, 767. PubMed


  • Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 Sep 30;329(14):977-86. PubMed


  • Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998 May 27;279(20):1615-22. PubMed


  • Ebeling P, Teppo AM, Koistinen HA, Koivisto VA. Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes. Metabolism 2001 Mar;50(3):283-7. PubMed


  • Ebrahim S, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. In: Cochrane Library [database online]. Issue 2. Oxford: Update Software; 1999 


  • Eckman MH, Greenfield S, Mackey WC, Wong JB, Kaplan S, Sullivan L, Dukes K, Pauker SG. Foot infections in diabetic patients. Decision and cost-effectiveness analyses. JAMA 1995 Mar 1;273(9):712-20. PubMed


  • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 Sep 12;352(9131):854-65. PubMed


  • Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial (DCCT) Research Group. Am J Cardiol 1995 May 1;75(14):894-903. PubMed


  • Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000 Jan 22;355(9200):253-9. PubMed


  • Ellison GC, Rayman KM. Exemplars' experience of self-managing type 2 diabetes. Diabetes Educ 1998 May-Jun;24(3):325-30. PubMed


  • Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000 Oct;23(10):1563-80. [187 references] PubMed


  • Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992 May;19(5):403-18. [279 references] PubMed


  • Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998 Mar 5;338(10):645-52. PubMed


  • Evanoff G, Thompson C, Brown J, Weinman E. Prolonged dietary protein restriction in diabetic nephropathy. Arch Intern Med 1989 May;149(5):1129-33. PubMed


  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 May 16;285(19):2486-97. PubMed


  • Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects. A criteria-based literature review. Diabetes Care 1997 Sep;20(9):1482-6. [22 references] PubMed


  • Fain JA, Melkus GD. Nurse practitioner practice patterns based on standards of medical care for patients with diabetes. Diabetes Care 1994 Aug;17(8):879-81. PubMed


  • Feste C. Empowerment: facilitation a path to responsible self care. Elkhart (IN): Miles, Inc., Diagnostic Division; 1991.


  • Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001 Jul 9;161(13):1581-6. PubMed


  • Franz MJ, Splett PL, Monk A, Barry B, McClain K, Weaver T, Upham P, Bergenstal R, Mazze RS. Cost-effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc 1995 Sep;95(9):1018-24. PubMed


  • Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987 Nov 12;317(20):1237-45. PubMed


  • Funnell MM, Haas LB. National Standards for Diabetes Self-Management Education Programs. Diabetes Care 1995 Jan;18(1):100-16. PubMed


  • Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study . Lancet 1999 Feb 20;353(9153):617-22. PubMed


  • Gall MA, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P, et al.. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991 Sep;34(9):655-61. PubMed


  • Garcia R, Suarez R. Diabetes education in the elderly: a 5-year follow-up of an interactive approach. Patient Educ Couns 1996 Oct;29(1):87-97. PubMed


  • Gerich JE. Novel insulins: expanding options in diabetes management. Am J Med 2002 Sep;113(4):308-16. [59 references] PubMed


  • Giacalone VF. Phenol matricectomy in patients with diabetes. J Foot Ankle Surg 1997 Jul-Aug;36(4):264-7; discussion 328. PubMed


  • Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 1983 Dec 22;309(25):1543-6. PubMed


  • Glasgow RE, Toobert DJ, Hampson SE, Brown JE, Lewinsohn PM, Donnelly J. Improving self-care among older patients with type II diabetes: the 'Sixty Something...' Study. Patient Educ Couns 1992 Feb;19(1):61-74. PubMed


  • Goodkin G. Mortality factors in diabetes. A 20 year mortality study. J Occup Med 1975 Nov;17(11):716-21.


  • Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989 Jan;79(1):8-15. PubMed


  • Haffner SM, Fong D, Stern MP, Pugh JA, Hazuda HP, Patterson JK, van Heuven WA, Klein R. Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes 1988 Jul;37(7):878-84. PubMed


  • Hamman RF, Mayer EJ, Moo-Young GA, Hildebrandt W, Marshall JA, Baxter J. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study. Diabetes 1989 Oct;38(10):1231-7. PubMed


  • Hanaire-Broutin H, Study Group for the Development of Pump Therapy in Diabetes, Melki V, Bessieres-Lacombe S, Tauber JP. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. Diabetes Care 2000 Sep;23(9):1232-5. PubMed


  • Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998 Jun 13;351(9118):1755-62. PubMed


  • Harris MI. Classification, diagnostic criteria, and screening for diabetes. In: National Diabetes Data Group. Diabetes in America. 2nd ed. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995.


  • Harris MI. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care 2001 Jun;24(6):979-82. PubMed


  • Henricsson M, Nilsson A, Janzon L, Groop L. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Diabet Med 1997 Feb;14(2):123-31. PubMed


  • Holewski JJ, Stess RM, Graf PM, Grunfeld C. Aesthesiometry: quantification of cutaneous pressure sensation in diabetic peripheral neuropathy. J Rehabil Res Dev 1988 Spring;25(2):1-10. PubMed


  • Home PD, Lindholm A, Hylleberg B, Round P. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group. Diabetes Care 1998 Nov;21(11):1904-9. PubMed


  • Home PD, Lindholm A, Riis A. Insulin aspart vs. human insulin in the management of long-term blood glucose control in type 1 diabetes mellitus: a randomized controlled trial. Diabet Med 2000 Nov;17(11):762-70. PubMed


  • Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O'Fallon WM, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med 1989 Nov 15;111(10):788-96. PubMed


  • Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997 Feb;46(2):271-86. PubMed


  • Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 2002 Jan 16;287(3):360-72. [154 references] PubMed


  • Jacobson JM, O'Rourke PJ, Wolf AE. Impact of a diabetes teaching program on health care trends in an Air Force Medical Center. Mil Med 1983 Jan;148(1):46-7. PubMed


  • Javitt JC, Aiello LP, Chiang Y, Ferris FL 3d, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care 1994 Aug;17(8):909-17. PubMed


  • Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996 Jan 1;124(1 Pt 2):164-9. PubMed


  • Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology 1989 Feb;96(2):255-64. PubMed


  • Johansen K. Efficacy of metformin in the treatment of NIDDM. Meta-analysis. Diabetes Care 1999 Jan;22(1):33-7. PubMed


  • Kawazu S, Tomono S, Shimizu M, Kato N, Ohno T, Ishii C, Murata K, Watanabe T, Negishi K, Suzuki M, et al.. The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study. J Diabetes Complications 1994 Jan-Mar;8(1):13-7. PubMed


  • Kirk JK, Pearce KA, Michielutte R, Summerson JH. Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes. J Fam Pract 1999 Nov;48(11):879-82. PubMed


  • Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994 Sep;112(9):1217-28. PubMed


  • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984 Apr;102(4):520-6. PubMed


  • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984 Apr;102(4):527-32. PubMed


  • Klein R, Klein BEK, Moss SE. The epidemiology of ocular problems in diabetes mellitus. In: Ferman SS, editor(s). Ocular problems in diabetes mellitus. Boston (MA): Blackwell Scientific Publications; 1992. p. 1-53.


  • Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989 Oct;96(10):1501-10. PubMed


  • Klein R, Moss SE, Klein BE. Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy. Ophthalmology 1993 Aug;100(8):1140-6. PubMed


  • Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995 Feb;18(2):258-68. [54 references] PubMed


  • Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 Feb 7;346(6):393-403. PubMed


  • Kohner EM, Stratton IM, Aldington SJ, Holman RR, Matthews DR. Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med 2001 Mar;18(3):178-84. PubMed


  • Kohner EM, Stratton IM, Aldington SJ, Turner RC, Matthews DR. Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group. Diabetologia 1999 Sep;42(9):1107-12. PubMed


  • Kouri TT, Viikari JS, Mattila KS, Irjala KM. Microalbuminuria. Invalidity of simple concentration-based screening tests for early nephropathy due to urinary volumes of diabetic patients. Diabetes Care 1991 Jul;14(7):591-3. PubMed


  • Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995 May 11;332(19):1251-5. PubMed


  • Lacourciere Y, Belanger A, Godin C, Halle JP, Ross S, Wright N, Marion J. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy. Kidney Int 2000 Aug;58(2):762-9. PubMed


  • Laffel LM, McGill JB, Gans DJ. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Am J Med 1995 Nov;99(5):497-504. PubMed


  • Lavery LA, Walker SC, Harkless LB, Felder-Johnson K. Infected puncture wounds in diabetic and nondiabetic adults. Diabetes Care 1995 Dec;18(12):1588-91. PubMed


  • Lazarus JM, Bourgoignie JJ, Buckalew VM, Greene T, Levey AS, Milas NC, Paranandi L, Peterson JC, Porush JG, Rauch S, Soucie JM, Stollar C. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension 1997 Feb;29(2):641-50. PubMed


  • Lee ET, Lee VS, Kingsley RM, Lu M, Russell D, Asal NR, Wilkinson CP, Bradford RH Jr. Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors. Diabetes Care 1992 Nov;15(11):1620-7. PubMed


  • Leng GC, Price JF, Jepson RG. Lipid-lowering for lower limb atherosclerosis (Cochrane Review). In: Cochrane Library [database online]. Issue 2. Oxford: Update Software; 2000 


  • Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993 Nov 11;329(20):1456-62. PubMed


  • Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001 Sep 20;345(12):851-60. PubMed


  • Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002 Mar 23;359(9311):1004-10. PubMed


  • Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, Ford ES, Vinicor F. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1993 Jul 1;119(1):36-41. PubMed


  • Lovell HG. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria. Cochrane Database Syst Rev 2001;(1):CD002183. [60 references] PubMed


  • Malinowski JM, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. Clin Ther 2000 Oct;22(10):1151-68; discussion 1149-. [47 references] PubMed


  • Malone JI, Morrison AD, Pavan PR, Cuthbertson DD. Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial. Diabetes Care 2001 Mar;24(3):522-6. PubMed


  • Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992 Jul 1;268(1):63-7. PubMed


  • Mayfield JA, Reiber GE, Nelson RG, Greene T. A foot risk classification system to predict diabetic amputation in Pima Indians. Diabetes Care 1996 Jul;19(7):704-9. PubMed


  • Mayfield JA, Reiber GE, Nelson RG, Greene T. Do foot examinations reduce the risk of diabetic amputation. J Fam Pract 2000 Jun;49(6):499-504. PubMed


  • Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes (technical review). Diabetes Care 1998 Dec;21(12):2161-77. PubMed


  • Meier JL, Swislocki AL, Lopez JR, Noth RH, Bartlebaugh P, Siegel D. Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control. Am J Manag Care 2002 Jun;8(6):557-65. PubMed


  • Merritt GJ, Kobernus CA, Hall NJ, Tanenberg RJ. Outcome analysis of a diabetic education clinic. Mil Med 1983 Jun;148(6):545-7. PubMed


  • Miller CK, Edwards L, Kissling G, Sanville L. Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial. Prev Med 2002 Feb;34(2):252-9. PubMed


  • Miller LV, Goldstein J. More efficient care of diabetic patients in a county-hospital setting. N Engl J Med 1972 Jun 29;286(26):1388-91.


  • Mogensen CE, Neldam S, Tikkanen I, Oren S, Viskoper R, Watts RW, Cooper ME. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000 Dec 9;321(7274):1440-4. PubMed


  • Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987 Feb;31(2):673-89. [174 references] PubMed


  • Monk A, Barry B, McClain K, Weaver T, Cooper N, Franz MJ. Practice guidelines for medical nutrition therapy provided by dietitians for persons with non-insulin-dependent diabetes mellitus. International Diabetes Center. J Am Diet Assoc 1995 Sep;95(9):999-1006; quiz 1007-8. PubMed


  • Morisaki N, Watanabe S, Kobayashi J, Kanzaki T, Takahashi K, Yokote K, Tezuka M, Tashiro J, Inadera H, Saito Y, et al.. Diabetic control and progression of retinopathy in elderly patients: five-year follow-up study. J Am Geriatr Soc 1994 Feb;42(2):142-5. PubMed


  • Muirhead N, Feagan BF, Mahon J, et al. The effects of valsartan and captopril on reducing microalbuminuria in patients with type 2 diabetes mellitus: a placebo-controlled trial. 1999;60:650-60.


  • Murray JE. Microalbuminuria in type II diabetes. Endocr Pract 1996;2:211-4.


  • Nakamura T, Ushiyama C, Shimada N, Hayashi K, Ebihara I, Koide H. Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients. J Diabetes Complications 2000 Sep-Oct;14(5):250-4. PubMed


  • Nathan DM, Fogel HA, Godine JE, Lou PL, D'Amico DJ, Regan CD, Topping TM. Role of diabetologist in evaluating diabetic retinopathy. Diabetes Care 1991 Jan;14(1):26-33. PubMed


  • Nelson RG, Newman JM, Knowler WC, Sievers ML, Kunzelman CL, Pettitt DJ, Moffett CD, Teutsch SM, Bennett PH. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1988 Oct;31(10):730-6. PubMed


  • Nielsen S, Dollerup J, Nielsen B, Jensen HA, Mogensen CE. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study. Nephrol Dial Transplant 1997;12 Suppl 2:19-23. PubMed


  • Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001 Mar;24(3):561-87. [127 references] PubMed


  • Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002 Jul;25(7):1159-71. PubMed


  • Norris SL, Nichols PJ, Caspersen CJ, Glasgow RE, Engelgau MM, Jack L, Snyder SR, Carande-Kulis VG, Isham G, Garfield S, Briss P, McCulloch D. Increasing diabetes self-management education in community settings. A systematic review. Am J Prev Med 2002 May;22(4 Suppl):39-66. [120 references] PubMed


  • Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995 May;28(2):103-17. PubMed


  • Oki JC, Flora DL, Isley WL. Frequency and impact of SMBG on glycemic control in patients with NIDDM in an urban teaching hospital clinic. Diabetes Educ 1997 Jul-Aug;23(4):419-24. PubMed


  • Opie LH, Schall R. Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy. J Am Coll Cardiol 2002 Jan 16;39(2):315-22. PubMed


  • Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Heart Association and the American Diabetes Association 18-20 September 1992, New Orleans, Louisiana. Diabetes Care 1993 Aug;16(8):1199-209. PubMed


  • Ordonez JD, Hiatt RA. Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population. Nephron 1989;51(4):524-9.


  • Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Cavazzini C, Furberg CD. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet 2000 Dec 9;356(9246):1949-54. PubMed


  • Palmberg P, Smith M, Waltman S, Krupin T, Singer P, Burgess D, Wendtlant T, Achtenberg J, Cryer P, Santiago J, White N, Kilo C, Daughaday W. The natural history of retinopathy in insulin-dependent juvenile-onset diabetes. Ophthalmology 1981 Jul;88(7):613-8. PubMed


  • Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997 Apr;20(4):537-44. PubMed


  • Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus [published erratum appears in Diabetologia 1987 May;30(5):364]. Diabetologia 1987 Mar;30(3):123-31. PubMed


  • Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001 Sep 20;345(12):870-8. PubMed


  • Pascale RW, Wing RR, Butler BA, Mullen M, Bononi P. Effects of a behavioral weight loss program stressing calorie restriction versus calorie plus fat restriction in obese individuals with NIDDM or a family history of diabetes. Diabetes Care 1995 Sep;18(9):1241-8. PubMed


  • Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990 May;13(5):513-21. PubMed


  • Pieber TR, Eugene-Jolchine I, Derobert E. Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes. Diabetes Care 2000 Feb;23(2):157-62. PubMed


  • Piette JD, Glasgow RE. Education and home glucose monitoring. In: Gerstein H, Haynes RB, editor(s). Evidence-based diabetes care. Ontario (CA): BC Decker, Inc.; 2001. p. 207-51.


  • Preventive foot care in people with diabetes. Diabetes Care 2000 Jan;23 Suppl 1:S55-6. PubMed


  • Rabb MF, Gagliano DA, Sweeney HE. Diabetic retinopathy in blacks. Diabetes Care 1990 Nov;13(11):1202-6. [19 references] PubMed


  • Rachmani R, Levi Z, Slavachevski I, Avin M, Ravid M. Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus--a randomized prospective study. Diabet Med 2002 May;19(5):385-92. PubMed


  • Raji A, Gomes H, Beard JO, MacDonald P, Conlin PR. A randomized trial comparing intensive and passive education in patients with diabetes mellitus. Arch Intern Med 2002 Jun 10;162(11):1301-4. PubMed


  • Rao G. Diagnostic yield of screening for type 2 diabetes in high-risk patients: a systematic review. J Fam Pract 1999 Oct;48(10):805-10. [22 references] PubMed


  • Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care 2000 May;23(5):583-8. PubMed


  • Raskin P, Rendell M, Riddle MC, Dole JF, Freed MI, Rosenstock J. A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes. Diabetes Care 2001 Jul;24(7):1226-32. PubMed


  • Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. study group of insulin glargine in type 1 diabetes. Diabetes Care 2000 May;23(5):639-43. PubMed


  • Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993 Apr 15;118(8):577-81. PubMed


  • Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In: Harris MI, et al, editor(s). Diabetes in America. 2nd ed. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995. p. 409-27, appendix 18.1.


  • Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 Jul;20(7):1183-97. PubMed


  • Rickheim PL, Weaver TW, Flader JL, Kendall DM. Assessment of group versus individual diabetes education: a randomized study. Diabetes Care 2002 Feb;25(2):269-74. PubMed


  • Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care 1992 Oct;15(10):1386-9. [18 references] PubMed


  • Rodby RA, Rohde RD, Sharon Z, Pohl MA, Bain RP, Lewis EJ. The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group. Am J Kidney Dis 1995 Dec;26(6):904-9. PubMed


  • Rosenstock J, Einhorn D, Hershon K, Glazer NB, Yu S. Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy. Int J Clin Pract 2002 May;56(4):251-7. PubMed


  • Rosenstock J, Park G, Zimmerman J. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group. Diabetes Care 2000 Aug;23(8):1137-42. PubMed


  • Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care 2001 Apr;24(4):631-6. PubMed


  • Rubin RJ, Dietrich KA, Hawk AD. Clinical and economic impact of implementing a comprehensive diabetes management program in managed care. J Clin Endocrinol Metab 1998 Aug;83(8):2635-42. PubMed


  • Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999 Aug 5;341(6):410-8. [37 references] PubMed


  • Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996 Oct 3;335(14):1001-9. PubMed


  • Savage S, Estacio RO, Jeffers B, Schrier RW. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. Proc Assoc Am Physicians 1997 Mar;109(2):181-9. PubMed


  • Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 1996 Nov;19(11):1243-8. PubMed


  • Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994 Nov 19;344(8934):1383-9. PubMed


  • Schlundt DG, Rea MR, Kline SS, Pichert JW. Situational obstacles to dietary adherence for adults with diabetes. J Am Diet Assoc 1994 Aug;94(8):874-6, 879; quiz 877-8. PubMed


  • Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995 Nov 16;333(20):1301-7. PubMed


  • Sikka R, Waters J, Moore W, Sutton DR, Herman WH, Aubert RE. Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes. Diabetes Care 1999 Jan;22(1):1-6. PubMed


  • Sims DS Jr, Cavanagh PR, Ulbrecht JS. Risk factors in the diabetic foot. Recognition and management. Phys Ther 1988 Dec;68(12):1887-902. PubMed


  • Singer DE, Nathan DM, Fogel HA, Schachat AP. Screening for diabetic retinopathy. Ann Intern Med 1992 Apr 15;116(8):660-71. PubMed


  • Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, Matthews DR. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001 Feb;44(2):156-63. PubMed


  • Tamas G, Marre M, Astorga R, Dedov I, Jacobsen J, Lindholm A. Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study. Diabetes Res Clin Pract 2001 Nov;54(2):105-14. PubMed


  • Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998 Apr;21(4):597-603. PubMed


  • The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention. JAMA 1998 Nov 25;280(20):1757-63. PubMed


  • Toto RD, Kirk KA, Coresh J, Jones C, Appel L, Wright J, Campese V, Olutade B, Agodoa L. Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. J Am Soc Nephrol 1997 Feb;8(2):279-87. PubMed


  • Travis T. Patient perceptions of factors that affect adherence to dietary regimens for diabetes mellitus. Diabetes Educ 1997 Mar-Apr;23(2):152-6. PubMed


  • Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 May 3;344(18):1343-50. PubMed


  • U.K. Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 Sep 12;352(9131):837-53. PubMed


  • U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995 Nov;44(11):1249-58. PubMed


  • UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998 Sep 12;317(7160):713-20. PubMed


  • UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [published erratum appears in BMJ 1999 Jan 2;318(7175):29]. BMJ 1998 Sep 12;317(7160):703-13. PubMed


  • United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy [trunc]. Ann Intern Med 1998 Feb 1;128(3):165-75. PubMed


  • Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 1994 Jan 26;271(4):275-9. PubMed


  • Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA 2000 Feb 16;283(7):889-96. PubMed


  • Vivian EM, Goebig ML. Slowing the progression of renal disease in diabetic patients. Ann Pharmacother 2001 Apr;35(4):452-63. [53 references] PubMed


  • Walker JD, Bending JJ, Dodds RA, Mattock MB, Murrells TJ, Keen H, Viberti GC. Restriction of dietary protein and progression of renal failure in diabetic nephropathy [published erratum appears in Lancet 1989 Dec 23-30;2(8678-8679):1540]. Lancet 1989 Dec 16;2(8677):1411-5. PubMed


  • Waugh HV, Addlesee AJ. A prototype model for renal vasculature and its application in haemodialyser miniaturization. Proc Inst Mech Eng [H] 1997;211(6):479-82. PubMed


  • Weir GC, Nathan DM, Singer DE. Standards of care for diabetes. Diabetes Care 1994 Dec;17(12):1514-22. [111 references] PubMed


  • Wieland LD, Vigil JM, Hoffman RM, Janis LW. Relationship between home glucose testing and hemoglobin Alc in type II diabetes patients. Am J Health Syst Pharm 1997 May 1;54(9):1062-5. PubMed


  • Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998 May 12;97(18):1837-47. PubMed


  • Yki-Jarvinen H, Dressler A, Ziemen M. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group. Diabetes Care 2000 Aug;23(8):1130-6. PubMed


  • Young MJ, Cavanagh PR, Thomas G, Johnson MM, Murray H, Boulton AJ. The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med 1992 Jan-Feb;9(1):55-7. PubMed


  • Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991 Jan 10;324(2):78-84. PubMed


© 1998-2009 National Guideline Clearinghouse

Date Modified: 2/16/2009

 

 

   
DHHS Logo